CD38 and plasma cell myeloma: CD38-specific nanobodies can be used either for the treatment of multiple myeloma by generation of nanobody-based heavy-chain antibodies (hcAbs) (22–26), nanobody-based CARs (27), and nanobody-based BiKEs (28), or for in vivo imaging of multiple myeloma (29).